1,551 results on '"Shao, Zhi-Ming"'
Search Results
2. Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection
3. BOLERO-5: a phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER + /HER2- advanced breast cancer
4. Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF
5. Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy
6. Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
7. Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
8. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients
9. Ipsilateral breast tumor recurrence after breast-conserving surgery: insights into biology and treatment
10. Radiomics in breast cancer: Current advances and future directions
11. Intratumor heterogeneity in breast cancer: Tracing its origins and translating findings into clinical practice
12. Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A
13. DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB
14. Molecular classification of hormone receptor-positive HER2-negative breast cancer
15. Deep learning framework for comprehensive molecular and prognostic stratifications of triple-negative breast cancer
16. Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities
17. Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer
18. Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer
19. Calcifications in triple-negative breast cancer: Molecular features and treatment strategies
20. High expression of TLR3 in triple-negative breast cancer predicts better prognosis—data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays
21. SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches
22. Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial
23. Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low Breast Cancer
24. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
25. CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration
26. Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer
27. Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
28. AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer
29. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria
30. Emerging therapies in cancer metabolism
31. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
32. CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer
33. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials
34. A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer
35. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
36. Artificial intelligence-based diagnosis of breast cancer by mammography microcalcification
37. Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting the TOLLIP-mediated autophagic degradation of CIP2A
38. Adjuvant chemotherapy guided by an integrated mRNA–lncRNA signature in triple-negative breast cancer (BCTOP-T-A01): A randomized, open-label, multicenter phase 3 trial.
39. The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer
40. The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target
41. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
42. Comments on: a prediction model for distant metastasis after isolated locoregional recurrence of breast cancer
43. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
44. O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression
45. A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers
46. Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis
47. Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
48. Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
49. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
50. SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.